Menu
  • Join
  • Login
  • Contact
 

Search abstracts


TRIPLE THERAPY WITH OLMESARTAN, AMLODIPINE, AND HYDROCHLOROTHIAZIDE IN PATIENTS WITH HYPERTENSION

  • At: 2015 FIP Congress in Düsseldorf (Germany)
  • Type: Poster
  • By: HUANG, Mei Jung (Show Chwan Memorial Hospital, Pharmacy, Changhua, China Taiwan)
  • Co-author(s): Mei-Jung Huang
  • Abstract:

    Hypertension is an increasingly prevalent cardiovascular risk factor associated with high rates of morbidity and mortality. Patients with hypertension may require a combination of ≥2 antihypertensive agents to achieve blood pressure (BP) control.

    We conducted a retrospective study data collected from July 2012 to February 2013. Totally 74 patients

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses